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ABSTRACT As key components of innate immune defense, macrophages are essential in controlling bacterial pathogens, includ-
ing group A Streptococcus (GAS). Despite this, only a limited number of studies have analyzed the recovery of GAS fromwithin
human neutrophils andmacrophages. Here, we determined the intracellular fate of GAS in humanmacrophages by using several
quantitative approaches. In both U937 and primary humanmacrophages, the appearance over time of long GAS chains revealed
that despite GAS-mediated cytotoxicity, replication occurred in viable, propidium iodide-negative macrophages. Whereas the
major virulence factor M1 did not contribute to bacterial growth, a GASmutant strain deficient in streptolysin O (SLO) was im-
paired for intracellular replication. SLO promoted bacterial escape from the GAS-containing vacuole (GCV) into the macro-
phage cytosol. Up to half of the cytosolic GAS colocalized with ubiquitin and p62, suggesting that the bacteria were targeted by
the autophagy machinery. Despite this, live imaging of U937macrophages revealed proficient replication of GAS after GCV rup-
ture, indicating that escape from the GCV is important for growth of GAS in macrophages. Our results reveal that GAS can repli-
cate within viable humanmacrophages, with SLO promoting GCV escape and cytosolic growth, despite the recruitment of au-
tophagy receptors to bacteria.
IMPORTANCE Classically regarded as an extracellular pathogen, GAS can persist within human epithelial cells, as well as neutro-
phils andmacrophages. Some studies suggest that GAS canmodulate its intracellular vacuole to promote survival and perhaps
replicate in macrophages. However, an in-depth single-cell analysis of the dynamics of survival and replication is lacking. We
usedmacrophage-like cell lines and primary macrophages to measure the intracellular growth of GAS at both the population
and single-cell levels. While CFU counts revealed no increase in overall bacterial growth, quantitative fluorescence microscopy,
flow cytometry, and time-lapse imaging revealed bacterial replication in a proportion of infected macrophages. This study em-
phasizes the importance of single-cell analysis especially when studying the intracellular fate of a pathogen that is cytotoxic and
displays heterogeneity in terms of intracellular killing and growth. To our knowledge, this study provides the first direct visual-
ization of GAS replication inside human cells.
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Group A Streptococcus (GAS) causes a wide variety of diseasesin immunocompetent individuals, from localized skin infec-
tions and recurrent bouts of tonsillitis to more life-threatening
invasive diseases, such as streptococcal toxic shock syndrome
(STSS) and necrotizing fasciitis (NF). Skin and pharyngeal epithe-
lia represent the primary sites ofGAS interactionwith the host (1).
Upon the invasion of epithelial cells, GAS can persist for several
days (2, 3). However, many strains fail to proliferate and there is
evidence that autophagy and the endolysosomal pathway contrib-
ute to the intracellular clearance of GAS (4, 5). Other studies have
suggested that internalization of GAS in host cells provides a safe
haven fromhost cell killing and antibiotic-mediated killing in vivo
(6, 7).
B and T cell-deficient mice exhibit a similar resistance to GAS
in comparison to immunocompetent mice (8), but depletion of
macrophages causes a substantial increase in bacterial dissemina-
tion and mortality (9, 10). However, the contribution of macro-
phages to disease outcome in humans is not clear. Thulin and
colleagues found that macrophages were a primary reservoir of
viable GAS in biopsy specimens from patients with invasive dis-
ease (11). The presence of a heavy bacterial load despite intrave-
nous antibiotic therapy, suggests that GAS can resist and/or evade
macrophage killing mechanisms. This finding was also supported
by in vitro observations, which implicated the surface protein M1
in avoidance fusion between GAS and azurophilic granules and
lysosomes in human neutrophils and monocyte-derived macro-
phages, respectively (12, 13).
Another important virulence factor inGAS-host interactions is
the pore-forming toxin streptolysin O (SLO). SLO is produced
and secreted as a monomer that binds cholesterol in cell mem-
branes and oligomerizes to form large transmembrane pores (14).
Upon macrophage phagocytosis, SLO activity causes a dose-
dependent form of apoptotic cell death among a population of
infected cells (15, 16). In vitro and in vivo data support the hypoth-
esis that SLO-induced toxicity contributes to GAS immune eva-
sion and increased virulence. Moreover, it is becoming increas-
ingly clear that SLO has other important intracellular functions
beyond cytotoxicity. SLO has been reported to prevent bacterial
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internalization in pharyngeal keratinocytes (17) and promote es-
cape from vacuoles in HeLa cells (18). However, it has also been
reported that in macrophages, GAS survives within a modified
vacuolated compartment that could serve as a replicative niche
(13). A more recent study indicated that SLO-mediated pore for-
mation does not promote bacterial escape from the GAS-
containing vacuole (GCV) in THP-1macrophages but rather pre-
vents vacuole acidification (19). However, GAS proliferation in
human macrophages has yet to be observed or quantified by
single-cell analysis. In this study, we used macrophage-like cell
lines and monocyte-derived primary macrophages together with
CFU-based assays, quantitative fluorescencemicroscopy, flow cy-
tometry, and time-lapse imaging to observe and measure the in-
tracellular growth of GAS at both the population and single-cell
levels. While CFU counts revealed no increase in overall bacterial
growth in these cells, microscopic examination revealed bacterial
replication in a proportion of infected primary and U937 macro-
phages. Replication occurred in the host cell cytosol, after SLO-
dependent phagosomal rupture, despite recruitment of au-
tophagy proteins to a subpopulation of cytosolic bacteria. Our
results suggest that despite the ability of macrophages to control
the net intracellular growth of GAS, cytosolic growth within mac-
rophage subpopulations might contribute to the virulence of this
pathogen.
RESULTS
M1T1 GAS replicates in U937 and primary human macro-
phages. To investigate if GAS can survive and replicate in human
macrophages, THP-1, U937, and humanmonocyte-derived mac-
rophages (hMDMs) were infected with the clinically isolated
M1T1 5448 strain. A decrease in the CFU count occurred between
3 and 9 h postuptake (hpu) in THP-1 cells, and no viable colonies
were recovered at 24 hpu (Fig. 1A). In contrast, CFU counts de-
creased more slowly between 3 and 9 hpu in U937 and hMDMs
and substantial bacterial numbers were recovered at 24 hpu. The
CFU count reflects the net bacterial load, which is the result of
bacterial replication and killing, as well as cytotoxic effects caused
by bacteria. To determine if the CFU counts in thesemacrophages
reflected killing and a replicating subpopulation of bacteria, fluo-
rescence microscopy was used to quantify the number of intracel-
lular bacteria in infected cells over time. M1T1 GAS grows in
chains of up to 10 cocci in vitro. To reduce the phagocytosis of
large chains (which might interfere with the quantification of in-
tracellular bacterial replication), a low-speed centrifugation step
was included prior to infection to remove longer chains of bacteria
in the inoculum. Numbers of bacteria per infected cell over time
were grouped into the following categories: 1 or 2, 3 to 5, 6 to 10,
and11. The majority (~80%) of the cells contained5 bacteria
at 0.5 hpu (Fig. 1B). In THP-1 macrophages, there was a steady
decline in the percentages of infected cells containing 3 to 5, 6 to
10, and11 bacteria between 3 and 9 hpu (Fig. 1B). In contrast,
the percentage of U937 cells containing 11 bacteria increased
significantly from 4% at 0.5 hpu to 35% at 6 and 9 hpu (Fig. 1C).
Similarly, the percentage of infected hMDMs containing11 bac-
teria increased from 2% after initial uptake to approximately 39%
at 9 hpu (Fig. 1D). Representative confocal microscopy images
revealed the accumulation of chains of cocci only in U937 and
hMDMs between 3 and 9 h (Fig. 1E). To visualize intracellular
replication within living macrophages, we imaged U937 cells in-
fected with green fluorescent protein (GFP)-M1T1 5448 for 10 h
by confocal microscopy in the presence of gentamicin to kill ex-
tracellular bacteria (for a video, see Movie S1 in the supplemental
material; representative still images are shown in Fig. 1F). Infected
cells containing only 1 to 5 bacteriawere selected, and imagingwas
initiated at 2 hpu. Images were then acquired at 20-min intervals
until 10 hpu. In a subpopulation of U937 cells, intracellular rep-
lication became evident from 3 and 4 hpu. From 5 hpu onward,
bacteria continued to replicate, forming long chains in some cells.
Collectively, these results show that M1T1 GAS can replicate in
human primary macrophages and U937 cells but not in THP-1
cells.
GAS replicates in PI-negative U937 macrophages. Previous
studies have shown that GAS induces rapid, dose-dependent ap-
optosis, as well as caspase-1-dependent pyroptosis, in mouse and
human macrophages (16, 20). Therefore, it was possible that the
observed intracellular replication was in dying cells. To measure
intracellular bacterial replication in viable intact cells only, pro-
pidium iodide (PI) was included following the infection of U937
cells withM1T1 5448GAS. PI enters cells and fluoresces only after
loss of plasmamembrane integrity. At 6 hpu, a significant increase
in the percentage of PI-negative cells containing11 bacteria was
detected, compared to that seen at 2 hpu (Fig. 2A). A concomitant
decrease in the percentage of PI-negative cells containing few bac-
teria (1-2) was observed at 6 hpu. Representative confocal micro-
scopic images of infected PI-positive and PI-negative cells at 2 and
6 hpu are shown in Fig. 2B. Although GAS is generally regarded as
being cytotoxic to macrophages, these results show that intracel-
lular bacterial replication can occur inside macrophages with in-
tact plasma membranes.
SLO is required for replicationofGAS inU937macrophages.
The outer surface M protein is one of the best-characterized viru-
lence factors of GAS and has been reported to promote intracel-
lular survival in humanmacrophages (13). To determine if theM1
protein is required for intracellular replication under our experi-
mental conditions, U937 cells were infected with isogenic wild-
type (WT) M1T1 5448 or a emm1 mutant strain. There was a
small but significant decrease in cytotoxicity at 9 and 24 hpu in the
emm1 mutant compared to the WT strain (Fig. 3A). However,
no difference in CFU counts (see Fig. S1 in the supplemental ma-
terial) or the percentage of infected cells containing11 bacteria
(scored microscopically) was detected when these strains were
compared (Fig. 3B and C). The intracellular growth of additional
emm-type strains in U937 cells was also determined. TheM12 and
M49NZ131 strains replicated similarly toM1T1, but theM28 and
M49 CS101 strains did not (see Fig. S2A and B). This suggests that
replication of GAS within U937 cells is not specific to the hyper-
virulent M1T1 strain.
To investigate the contribution of the pore-forming toxin SLO,
a strain lacking the toxinwas compared to its isogenicM49NZ131
WT strain. As expected, the slo mutant was considerably less
toxic to U937 cells than WT M49 NZ131 was (Fig. 3D). Despite
the reduced cytotoxicity, no difference between theCFU counts of
the two strains was recorded (see Fig. S3 in the supplemental ma-
terial). However, microscopic analysis confirmed that the slo
mutant was significantly impaired in intracellular replication
compared to the isogenic WT strain. At 9 hpu, only 7% of the
infected cells contained11slomutant bacteria while 20% con-
tained11 WT bacteria (Fig. 3E). Microscopic examination also
revealed that the slo mutant strain did not form the long repli-
cating chains observed in theWT andemm1 strains (Fig. 3F). As
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FIG 1 Quantification of intracellular M1T1 GAS in human macrophages. (A) Survival of M1T1 5448 GAS in the cell lines indicated. Cells were infected at an
MOI of 5, and intracellular bacteria were measured by CFU counting at the time points indicated. The mean  SEM of three independent experiments in
triplicate wells and duplicate colony counts is shown. (B to D) Quantification of intracellular GFP-M1T1 5448 in the cell lines indicated. Cells were infected at
anMOI of 0.5, and the percentage of cells containing 1 or 2, 3 to 5, 6 to 10, or11 bacteria per infected cell was scored by fluorescencemicroscopy. The numbers
of bacteria in at least 100 infected cells per experiment were determined. The mean SEM of at least three independent experiments is shown. *, P 0.05; **,
P 0.01; ***,P 0.001 (two-tailed paired t test). (E) Representative confocalmicroscopy images ofmacrophages infectedwithGFP-M1T1 5448GAS at the time
points indicated. Intracellular bacteria (in) were discriminated from extracellular bacteria (out) by differential labeling with an anti-GAS primary antibody and
an Alexa Fluor 555-conjugated secondary antibody (red) without cell permeabilization (scale bars, 5m). Cell outlines are delineated by broken white lines. (F)
Stills from live confocal imaging of U937 cells infected with GFP-M1T1 5448 at an MOI of 0.5. Imaging was initiated at 2 hpu, and the cells were imaged every
20 min until 10 hpu. The elapsed time is shown at the bottom left of each image (scale bars, 5 m).
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an independent measure of intracellular replication, the geomet-
ric mean fluorescence intensity of antibody-labeled WT and slo
mutant GAS per infected cell was determined by flow cytometry.
In agreement with the results obtained by microscopy, signifi-
cantly greater replication of the WT strain than the slo mutant
was detected at 6 and 9h, despite similar bacterial burdens at 1 hpu
(Fig. 3G and H). These results show that SLO is required for rep-
lication of GAS in U937 macrophages.
SLO reduces association of LAMP1withGAS. Fusion of lyso-
somes to the phagosome is an essential microbicidal mecha-
nism of macrophages (21). Reports on the intracellular local-
ization and trafficking of GAS vary widely, possibly reflecting
strain variations and different analytical techniques. The local-
ization of WTM49 NZ131 and slomutant strains after uptake
into U937 macrophages was determined by labeling infected
cells for LAMP1. Over 95% of heat-killed (HK) bacteria were at
least partially surrounded by LAMP1 at 2 hpu. In slo mutant-
infected cells, approximately 80% of the GAS bacteria were
associated with LAMP1, whereas in cells infected with WT bac-
teria, the association was significantly reduced, to 50% at 2 hpu
(Fig. 4A and B). An acidotropic LysoTracker dye was then used
to label phagolysosomes. Whereas the majority of WT bacteria
did not colocalize with LysoTracker, approximately 60% of the
slo mutant-containing GCVs had undergone acidification at
2 hpu (Fig. 4C and D). The finding that approximately 50% of
the WT GAS bacteria were LAMP1 associated at 2 hpu but only
21% were colabeled with LysoTracker suggests that GAS might
prevent phagolysosomal maturation, as well as mediate escape
from the GCV.
SLO is required for GCV rupture and bacterial escape into
the cytosol.The reduced association of LAMP1withWTGAS but
not the slomutant might also be due to SLO-mediated bacterial
escape from the phagosome. Therefore, we tested if cytosolic GAS
was present in U937 macrophages. Digitonin was used at a con-
centration that selectively permeabilized the plasmamembrane so
that only cytosolic GAS bacteria were immunolabeled with an
anti-GAS antibody. The luminal contents of intact phagosomes
remained inaccessible to the antibody, as indicated by the yellow
arrows in Fig. 5A. HK bacteria were very rarely observed in the
cytosol (Fig. 5A, top). In contrast, WT M49 NZ131 bacteria were
more readily found in the cytosol (Fig. 5A, bottom), confirming
the presence of cytosolic GAS within U937macrophages. Ubiqui-
tin frequently decorates cytosolic bacteria (22, 23), acting as a
signal for autophagy receptors such as p62 to direct the antibacte-
rial autophagy machinery toward such bacteria. Indeed, antibac-
terial autophagy has been reported to restrict the growth ofGAS in
epithelial cells (18, 24). To determine the proportion of cytosolic
GAS that was recognized in the cytosol by the ubiquitin-mediated
host detection system, U937 cells were infected with GAS strain
M49 NZ131 for different time periods, exposed to digitonin, and
then immunolabeled for ubiquitin or p62 prior to fixation (Fig. 5B
to E). Approximately 45% of the cytosolic bacteria colocalized
with ubiquitin at 1 hpu (Fig. 5C). A similar percentage (40%) of
ubiquitin colocalization was found at 3 hpu, and by 6 hpu, more
than half (59%) of the cytosolic bacteria were associated with
ubiquitin. Approximately 40% of the cytosolic GAS bacteria colo-
calized with the ubiquitin-LC3 cargo receptor p62 at 1 hpu, sim-
ilar to levels of ubiquitin colocalization (Fig. 5E). These data con-
firm the presence of cytosolic WT GAS within U937 cells and
suggest that approximately 50%of such bacteriamight be targeted
for antibacterial autophagy.
As various strains of GAS are efficiently targeted for degrada-
tion in LC3-positive autophagosomes within epithelial cells (8,
25), the proportion of GAS bacteria within autophagosomes was
quantified in U937 macrophages. GFP-LC3 colocalization with
total bacteria was quantified after permeabilization with saponin,
since bacteria enclosed in an autophagosome would no longer be
cytosolic. We found that 26% of the total intracellular bacteria
were associated with LC3 at 1 hpu and that LC3 recruitment was
significantly lower in slo mutant-infected cells, consistent with
SLO-mediated rupture of the phagosome (Fig. 6A and B). Slightly
lower levels of LC3-positive GAS bacteria of theM1T1 5448 strain
were also observed, suggesting that this finding is not strain type
specific (see Fig. S4 in the supplemental material).
GAS replicates in the cytosol of U937 macrophages. One re-
cent study reported that M1T1 GAS avoids recognition of au-
tophagy in epithelial cells (26). Since not all cytosolic bacteriawere
targeted for ubiquitin- and p62-mediated antibacterial au-
FIG 2 Growth of M1T1 GAS in PI-negative U937 cells. (A) Quantification of intracellular GFP-M1T1 5448 in PI-negative cells at 2 and 6 hpu. The
number of bacteria in at least 50 infected cells per experiment was determined (mean SEM, n 3). (B) Representative confocal microscopy images of
PI-positive (red) or PI-negative cells infected with GFP-M1T1 5448 at the time points indicated (scale bars, 5 m). *, P  0.05; **, P  0.01 (two-tailed
paired t test).
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FIG 3 SLO is required for intracellular replication of GAS. (A) Cytotoxicity of isogenicWTM1T1 5448 and theemm1mutant presented as a percentage of the
maximumLDH release. Themeans SEMof three independent experiments in triplicate wells are shown. (B) U937macrophages were infected withWTM1T1
5448 or theemm1mutant, and the percentage of infected cells containing11 bacteria was determined. The bacteria in at least 100 infected cells per experiment
were counted. NS, not significant. (C) Representative confocal microscopy images of U937 cells infected withWTM1T1 5448 or theemm1mutant at the time
points indicated. Intracellular bacteria (in) were discriminated from extracellular bacteria (out) by differential labeling with an anti-GAS primary antibody and
an Alexa Fluor 555-conjugated secondary antibody (red) without permeabilization (scale bars, 5 m). Cell outlines are delineated by broken white lines. (D)
Cytotoxicity of isogenic WT M49 NZ131 and slo mutant strains presented as a percentage of the maximum LDH release. The means  SEM of three
independent experiments in triplicate wells are shown. (E) Cells were infected with WT M49 NZ131 or the slo mutant, and the number of infected cells
containing11 bacteria was determined. The bacteria in at least 100 infected cells per experiment were counted. (F) Representative confocal microscopy images
of U937 cells infected with WTM49 and the slomutant at the time points indicated (scale bars, 5 m). (G.1 to G.3) Representative contour plots showing the
fluorescence profile of antibody-labeledWTM49 NZ131 and the slomutant in U937 cells, including uninfected cells, at 9 hpu. Black boxes indicate the gating
for the infected-cell population, and blue boxes indicate the gating for infected cells containing high numbers of fluorescent bacteria. (H) Geometric mean
fluorescence intensity at 488 nm (gMF488) of WTM49 NZ131 and the slomutant in U937 cells across all of the time points examined. The mean SEM of at
least three independent experiments is shown. *, P 0.05; **, P 0.01; ***, P 0.001 (two-tailed paired t test).
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tophagy, this suggests that a subpopulation of cytosolic GAS
within macrophages is not recognized for autophagy-mediated
growth attenuation. Furthermore, we noted that cytosolic WT
GAS bacteria were often found in large numbers within one cell
(Fig. 5A), which could indicate cytosolic bacterial replication. To
test this more directly, the percentages of infected U937 cells con-
taining at least one cytosolic bacteriumwere quantified at 1, 3, and
6 hpu (Fig. 7A). As our results with LAMP1 labeling suggested that
SLO mediates escape from the phagosome, the proportion of cy-
tosolic slo mutant bacteria was also quantified. Cytosolic WT
bacteria were present in 45% of the infected cells at 1 hpu and in
64% of them at 6 hpu. This was significantly higher than the per-
centage of cells containing cytosolic slo mutant bacteria, which
ranged from20 to 25%between 1 and 6 h.Next, the percentages of
cytosolic WT and slo mutant bacteria were quantified (Fig. 7B).
Cytosolic bacteria accounted for 31 and 33% of the total WT bac-
teria at 1 and 3 hpu, respectively. At 6 hpu, the earliest time point
of replication, the percentage of cytosolic bacteria increased sig-
nificantly to 49%. In contrast, the percentage of cytosolic slo
mutant bacteria ranged from 14 to 17% between 1 and 6 hpu,
significantly less than cytosolic WT bacteria at each time point.
Finally, when infected cells containing20WT bacteria were an-
alyzed, 84.6% 3.2% (mean standard error of themean [SEM]
of three experiments) of the bacteria were cytosolic. Together, this
indicates that GAS undergoes replication in the cytosol following
vacuole rupture.
Time-lapse imaging of GFP-M1T1 5448-infected U937 cells
expressingmCherry-tagged galectin 3 (27) was used to investigate
more directly the fate of GAS after damage of the vacuole and
entry into the macrophage cytosol (for a representative video, see
Movie S2 in the supplementalmaterial; still images are shown in in
Fig. 7C). Infected cells containing only 1 or 2 galectin 3-associated
FIG 4 SLO reduces association of LAMP1 with GAS. (A) U937 cells were infected with live or HKWTM49 NZ131 or the slomutant at an MOI of 5. Bacteria
were labeled with anti-GAS antibody (green) and anti-LAMP1 antibody (red), and DNA was stained with 4=,6-diamidino-2-phenylindole (DAPI; blue).
Representative confocal microscopy images obtained at 2 hpu are shown with higher magnifications of boxed areas (scale bars, 5m). (B) Quantification of the
colocalization of the GAS strains indicated and LAMP1. Data represent the results of at least 100 infected cells in each of three independent experiments
(mean SEM). (C) U937 cells were infected with live or HK WT M49 NZ131 or the slo mutant at an MOI of 5. LysoTracker dye was added to infected
cells 15 min prior to each time point. Bacteria were labeled with anti-GAS antibody (green). LysoTracker-positive acidic compartments are red, and DNA
stained with DAPI is blue. Representative confocal microscopy images obtained at 2 hpu are shown with higher magnifications of boxed areas (scale bars,
5 m). (D) Quantification of GAS colocalization with LysoTracker dye. Data shown represent the results of at least 100 infected cells in three independent
experiments (mean  SEM). *, P  0.05; **, P  0.01; ***, P  0.001 (two-tailed paired t test).
O’Neill et al.
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FIG 5 GAS bacteria rupture the GCV and escape into the macrophage cytosol. (A) Representative confocal microscopy images of U937 cells infected with HK
orWTM49NZ131 GAS at anMOI of 0.5. Cytosolic bacteria were labeled following digitonin-mediated semipermeabilization of the plasmamembrane (green),
followed by labeling of total bacteria (red) with saponin at 6 hpu. Yellow arrows indicate vacuolar bacteria. DNAwas stainedwithDAPI (blue) (scale bars, 5m).
(B) Representative confocalmicroscopy images of cytosolicM49NZ131GAS immunolabeledwith antiubiquitin antibodies in digitonin-treatedU937 cells at the
time points indicated. Ub, ubiquitin. (C) Quantification of ubiquitin colocalization among cytosolic GAS bacteria. At least 100 infected cells were scored in at
least three independent experiments (mean  SEM). (D) Representative confocal microscopy images of cytosolic M49 NZ131 GAS immunolabeled with
anti-p62 antibodies in digitonin-treated U937 cells. (E) Quantification of p62 colocalization among cytosolic bacteria. At least 100 infected cells were scored in
at least three independent experiments (mean SEM).
Cytosolic Replication of Group A Streptococcus
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bacteria were selected, and imaging was initiated at 2 hpu. Images
were acquired at 20-min intervals until 10 hpu. In 31% of the
selected cells, the formation of a rapidly expanding coccal chain
was observed after the recruitment of galectin 3 to the damaged
vacuole. From 2 to 4 hpu, a single coccus replicated to form a long
chain consisting of20 cocci. As the bacteria replicated, a residual
galectin 3 signal was apparent at the poles of the expanding coccal
chain (indicated by arrows); this wasmost likely to be remnants of
the ruptured vacuolar membrane. Bacterial replication was fre-
quently followed by loss of normal macrophage morphology and
galectin 3 fluorescence, consistent with a loss of membrane integ-
rity and resulting cell death.
Collectively, these results indicate that SLO-mediated rupture
of the GCVmembrane generates a significant proportion of cyto-
solic bacteria. Some of the cytosolic bacteria are then recognized
by ubiquitin and the autophagy receptor p62, resulting in LC3
association with bacteria. However, antibacterial autophagy ap-
pears to be insufficient to fully control bacterial replication, as
shown by the presence of cells containing large numbers of cyto-
solic bacteria and live imaging of GAS replicating in the host cell
cytosol.
DISCUSSION
AlthoughGAS is amajor human-adapted bacterial pathogen, sur-
prisingly little is known about its fate in human macrophages. To
date, only one study has provided tentative evidence that GAS can
survive and replicate in human macrophages (13). In many GAS-
host cell interaction studies (13, 16, 19), CFU assays have been
used to measure the survival of the total GAS population, which
includes the intracellular bacteria, as well as the extracellularly
released bacteria recovered during a period after antibiotic with-
drawal from the cell culture medium. This technique therefore
fails to distinguish between intracellular replication and extracel-
lular replication after host cell lysis. Under our conditions, where
extracellular bacterial replication was inhibited by the continued
presence of antibiotic, GAS bacteria were found to survive longer
in U937 and primary macrophages than in THP-1 macrophages.
However, CFU counts reflect both replication and killing sus-
tained by the bacteria and host cell cytotoxic effects, which could
expose intracellular bacteria to antibiotic in themedium, resulting
in their death. For these reasons, CFU counts do not necessarily
represent an accurate measurement of intracellular survival
FIG 6 SLO stimulates targeted autophagy. (A) Representative confocal microscopy images of GFP-LC3 (green) U937 cells infected with WTM49 NZ131 GAS
and theslomutant. Bacteria were labeled with anti-GAS antibody (red) andDNAwas stained with DAPI (blue) at the time points indicated. (B) Quantification
of LC3 colocalization with WT and slo mutant bacteria. At least 100 infected cells were scored in at least three independent experiments (mean SEM). The
region of colocalization is magnified (boxed areas) (scale bars, 5 m). *, P 0.05; two-tailed paired t test.
O’Neill et al.
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and/or replication of GAS. Therefore, we used fluorescence mi-
croscopy to count bacteria and showed that GAS can replicate
within U937 and primary macrophages but not in THP-1 cells.
We identified a subpopulation of macrophages with hyperrepli-
catingGAS (defined as11GASbacteria per cell), including some
cells that were packed with numerous bacteria. The extensive rep-
lication and striking formation of long GAS chains were also ob-
served by time-lapse microscopy and flow cytometry in U937
macrophages. Since GAS induces macrophage cytotoxicity (16),
we quantified growth from 2 to 6 hpu in PI-negative cells and
showed that GAS can replicate inmacrophages before the onset of
host cell death. Moreover, during microscopic quantification of
infected cells, intracellular bacteriawere differentiated fromextra-
cellular bacteria by labeling with anti-GAS antibody without per-
meabilization of the host cell membrane. Since only cells with
intact cell membranes can restrict the entry of extracellular anti-
bodies, this provides indirect evidence that themajority of the cells
containing intracellular replicating bacteria (11) were viable.
The ability of GAS to replicate efficiently in U937 cells was not
specific to the hypervirulent M1T1 serotype but was also found in
an M12 throat isolate and the M49 NZ131 nephritogenic strain
(28). This suggested that the presence of the M1 protein, previ-
ously reported to mediate resistance to phagocytic killing in vitro
(13, 29), was not required to enable bacterial replication in our
experiments. Furthermore, we found no difference in survival or
replication between theWTand theemm1mutant inU937mac-
rophages. Instead, we found an essential role for SLO in promot-
ing the intracellular replication of NZ131M49GAS. Although the
slomutant was defective for intracellular replication and caused
significantly less cytotoxicity than the WT M49 strain, no signifi-
cant difference in CFU counts were recorded. This further illus-
trates the limitations of population-based methods in examining
the contribution of GAS virulence factors to intracellular survival
and/or replication. Despite exerting a cytotoxic effect, several
studies have reported that expression of SLO increases the recov-
ery of GAS from epithelial cells compared to that of a SLO-
deficient strain (16, 30). However, the mechanism by which SLO
promotes survival is uncertain. It has been reported that GAS
lacking SLO undergoes enhanced interactions with late endo-
somal acidified compartments compared to the WT strain, lead-
ing to the suggestion that SLO prevents lysosomal fusion to the
GCV (4, 17). However, this might also be explained by a larger
FIG 7 Replication of GAS after rupture of the GCV. U937 cells were infected with M49 NZ131 or sloGAS at an MOI of 0.5 and permeabilized with digitonin
to quantify the infected cells containing at least one cytosolic bacterium (A) or the total cytosolic bacteria in infected cells (B) at 1, 3, and 6 hpu. Themean SEM
of at least three independent experiments is shown (scale bars, 5 m). *, P 0.05; **, P 0.01 (two-tailed paired t test). (C) Stills from live confocal imaging of
mCherry-tagged galectin 3-expressing U937 cells infected with GFP-M1T1 5448 GAS at anMOI of 0.5. Imaging was initiated at 2 hpu, and the cells were imaged
every 20 min until 10 hpu. The elapsed time is shown at the bottom left of each image. Each yellow arrow highlights a single coccus that replicates to form a long
chain, as well as its association with mCherry galectin 3. This region is magnified and shown in the white box in the upper right of each image. The still images
are representative of 22 infected cells in four independent live-imaging experiments (scale bars, 5 m).
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cytosolic population of WT GAS bacteria than of a SLO-deficient
strain. Indeed, GAS bacteria are exposed to the cytosol in skin
keratinocytes and SLO pores can promote the survival of GAS in
autophagosome-like structures, which eventually fuse to become
autolysosomes but at a lower rate than that of a SLOmutant (30).
Finally, as two independent studies failed to observe cytosolicGAS
in human macrophages, it remains possible that, under certain
conditions, GAS could replicate in amodified vacuole throughout
infection (13, 19). We found that approximately 60% of the WT
bacteria were associated with LAMP1 at 1 hpu in U937 macro-
phages while 20% of the WT GCVs underwent acidification at
this time point. This suggests thatGASmight prevent acidification
of the GCV (19), as well as promote bacterial entry into the
nutrient-rich cytosol of U937macrophages, through SLO. In sup-
port of SLO-dependent GCV rupture, digitonin-mediated per-
meabilization of the plasma membrane revealed that at 6 hpu,
49% of the WT GAS bacteria were cytosolic, compared to 17% of
the slo mutant GAS bacteria. In the complete absence of SLO,
cytotoxicity, vacuole rupture, and bacterial replication were dras-
tically reduced. Nevertheless, a proportion of the SLO-expressing
GAS bacteria failed to rupture the GCV and replicate. This might
be due to variations in the level of SLO produced by different
intracellular bacteria.
Several previous studies have shown that selective autophagy
can restrict the growth of M6 (18), M49 (31), M89 (24), and M3
(30) strains of GAS. However, it was reported recently that the
M1T1 5448 strain avoids recognition by autophagy proteins such
as ubiquitin and NDP52, preventing LC3-mediated autophago-
some recruitment (26). This was attributed to the proteolytic ac-
tivity of the cysteine protease SpeB. As a result of impaired au-
tophagic recognition, this strain was found to replicate in the
cytosol of HeLa cells. Since the strains used in our study express
SpeB, we tested whether autophagy proteins were recruited to
cytosolic bacteria inU937macrophages.We found that between 1
and 6 hpu, 40 to 50% of the cytosolic M49 NZ131 bacteria were
recognized by ubiquitin and p62, and at 3 hpu, 32 and 24% of the
total WT M49 and M1T1 GAS bacteria associated with LC3, re-
spectively. These results are different from the findings of Barnett
et al., who showed that at 4 hpu in HeLa cells, only 3% of the WT
M1T1 GAS bacteria associated with LC3, whereas 26% of the
speB mutant bacteria were associated with this autophagy
marker (26). Therefore, while SpeB-mediated avoidance of au-
tophagy is active in epithelial cells, it appears to have aminor effect
in macrophages. Whether other virulence factors support the
growth of cytosolicGAS inmacrophages by disrupting autophagic
signaling or downstream maturation/fusion events needs to be
investigated further.
A recent study showed that GAS replicates in nonacidic
LAMP1- and LC3-positive vacuoles in endothelial cells (32). In
contrast, we found that where cells contained a large number of
bacteria, they were predominantly cytosolic. Furthermore, time-
lapse microscopy of infected galectin 3-expressing U937 cells re-
vealed that rupture of the GCV was followed immediately by bac-
terial replication in the cytosol. Strikingly, the galectin signal was
frequently localized at both ends of the expanding coccal chain,
suggesting that remnants of the ruptured membrane are forced
away fromdividing bacteria. This shows that replication ofGAS in
human macrophages occurs predominantly within the cytosol.
MATERIALS AND METHODS
Bacterial strains and growth conditions. GAS strain 5448 is a clinical
isolate obtained from a patient with NF and STSS and is representative of
the globally disseminated M1T1 clone (33). WT M1T1 5448, GFP-5448,
and the mutant lacking the M1 protein (emm1) were provided by A.
Norrby-Teglund (13). The serotype M49 NZ131 strain is a skin isolate
from a patient with glomerulonephritis (28). S. Sriskandan provided
NZ131, the mutant lacking the SLO toxin (slo), an M28 clinical throat
isolate, and the M49 CS101 strain first isolated and characterized by P.
Cleary. GAS strains were routinely grown at 37°C in a standing culture for
16 h until stationary phase in Todd-Hewitt broth (THB; Oxoid) supple-
mented with 1% yeast extract.
Antibodies and reagents. Macrophage colony-stimulating factor
(MCSF; ImmunoTools), phorbol 12-myristate 13-acetate (PMA; Sigma),
LysoTracker Red DND-99 (Molecular Probes), PI (Life Technologies),
heat-inactivated human serum (Sigma), and Accutase (Sigma) were used.
The primary antibodies were a goat anti-groupA polysaccharide antibody
(Abcam), a mouse anti-LAMP1 antibody (BD Bioscience), a mouse anti-
ubiquitin antibody (FK2; Enzo), and a mouse anti-SQSTM1 (p62) anti-
body (Abcam). The secondary antibody was an Alexa Fluor-conjugated
donkey anti-mouse or donkey anti-goat antibody (Invitrogen).
Cell culture and primary monocyte isolation. The THP-1 and U937
human monocytic cell lines were originally obtained from the ATCC.
THP-1 cells were maintained at 2  105/ml in RPMI medium (Gibco)
supplemented with 10% heat-inactivated fetal calf serum (FCS; Invit-
rogen), 2 mM L-glutamine (Sigma), 10 mM HEPES (Sigma), 1 mM
sodium pyruvate (Sigma), 2.5 g/liter glucose (Sigma), and 0.05 mM
-mercaptoethanol (Sigma) at 37°C in 5% CO2. U937 cells were main-
tained at 1 106/ml of RPMI medium supplemented with 10% FCS and
2 mM L-glutamine. To obtain a macrophage-like state, THP-1 and U937
cells were differentiated in 25 ng/ml PMA for 3 days. Peripheral blood
mononuclear cells (PBMCs) were isolated from the blood of healthy hu-
man volunteers after informed consent and in accordance with the ethical
guidelines of Imperial College, London. PBMCs were isolated by density
gradient centrifugation with Ficoll-Paque Plus (GE Healthcare) and
transferred to RPMI medium containing 10% FCS supplemented with
100 U/ml penicillin-streptomycin (Sigma). Red blood cells (RBC) were
lysed in Hybri-Max RBC-lysing buffer (Sigma) for 10 min at 37°C, cen-
trifuged, and resuspended in RPMImedium. Cells were counted and sub-
jected to CD14-positive selection (Miltenyi Biotec), according to the
manufacturer’s instructions. CD14-positive monocytes were differenti-
ated in 20 ng/ml MCSF and seeded onto 24-well plates at 2  105/ml.
MCSF was removed after 3 days and replaced with fresh RPMI medium
for a further 4 days. Cells were cultured in antibiotic-free medium 24 h
prior to infection.
Macrophage infection. Differentiated macrophages were cultured in
24-well plates at a density of 2  105/well or in 6-well plates at 1 
106/well. GAS was grown until stationary phase at 37°C in THB. Prior to
infection, long chains of GAS bacteria were removed from the infection
inoculum by a precentrifugation step as follows. The bacterial culture was
pelleted and resuspended in warm RPMI containing 10% FCS. One mil-
liliter of culture was added to each Eppendorf tube and pelleted at 1,000
g for 1 min. The top half of each supernatant (containing an enriched
mixture of single-coccus, diplococcus, and small-chain-forming GAS)
was combined and pelleted at top speed. Each pellet was resuspended in
RPMI and concentrated into a single tube. Bacteria were opsonized in
10% heat-inactivated human serum at room temperature for 20 min.
Bacteria were added to the cells at amultiplicity of infection (MOI) of 5 or
0.5 and centrifuged at 110  g for 5 min to increase and synchronize
infection. After incubation for 30 min at 37°C in 5% CO2, cells were
washed twice and incubated with 100 g/ml gentamicin for 1 h and then
with 25 g/ml gentamicin thereafter.
Bacterial survival and cytotoxicity. Bacterial intracellular survival
was determined by CFU counting on THB agar plates. At selected times
postuptake, cells were washed three times with PBS and lysed in 0.05%
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Triton X-100 in phosphate-buffered saline (PBS) for 5 min. The cell ly-
sates was serially diluted in PBS, and the number of CFU was determined
after plating onto THB agar plates. Bacterial survival was measured as the
total number of CFU per milliliter. Cytotoxicity was determined by the
lactate dehydrogenase (LDH) release assay. Prior to infection, the normal
cell culture medium was replaced with phenol-free RPMI medium
(Gibco) containing the appropriate supplements, as previously described.
Cells were infected at anMOI of 0.5, and at selected times postuptake, cell
culture supernatants were removed from each well and centrifuged to
pellet any suspended cells. The supernatant was removed and kept at
20°C until all samples were collected. Cytotoxicity was determined by
measuring the amount of LDH released into the cell culturemediumwith
the CytoTox 96 nonradioactive cytotoxicity assay (Promega), according
to the manufacturer’s instructions. Fifty microliters of supernatant was
mixed with 50l of substrate reagent and incubated at room temperature
in the dark. Absorbance at 490 nm was measured, and cytotoxicity was
calculated as follows: (sample LDH release spontaneous LDH release)/
(maximum LDH release spontaneous LDH release) 100. The maxi-
mum LDH release was determined by freezing replicate uninfected wells
at80°C for 30 min and harvesting the supernatants after thawing. The
spontaneous LDH release was determined by harvesting supernatants
from uninfected wells throughout the experiment.
Immunofluorescence microscopy. For visualization and quantifica-
tion of intracellular bacteria, differentiated macrophages were seeded
onto glass coverslips in 24-well plates and infected with GAS strains as
described previously. At the selected times postuptake, coverslips were
washed and fixed in 3% paraformaldehyde (PFA) in PBS for 15 min.
Primary antibodies were diluted to the appropriate working concentra-
tion in 10%horse serum (HS) in PBS containing the permeabilizing agent
saponin (0.1%) and added to the cells for 1 h. Cells were washed twice in
PBS and incubated with an Alexa Fluor-conjugated secondary antibody
containing 10% HS with 0.1% saponin. Cells were washed twice in PBS
and once in distilled H2O and mounted onto a microscope slide. Fixed
cells were imaged with a laser-scanning microscope (LSM710; Zeiss). Ac-
quired images were processed and false colored with the Zeiss imaging
software or Adobe Illustrator software. For bacterial in/out labeling, ex-
tracellular bacteria were labeled with primary (anti-GAS) and secondary
antibodies without permeabilization, and then intracellular bacteria were
differentially labeled with an anti-GAS primary antibody and a different
Alexa Fluor-conjugated secondary antibody in the presence of saponin. In
GFP-M1T1 5448-infected cells, extracellular bacteria were labeledwith an
anti-GAS antibody and a Alexa Fluor 555-conjugated secondary antibody
in the absence of permeabilization. For LysoTracker Red labeling, infected
cells were incubated with 40 nM LysoTracker probe for 15 min prior to
fixation.
Flow cytometry. U937 cells were seeded in six-well plates at 1 106/
ml, differentiatedwith PMA for 3 days, and infectedwith the isogenicM49
NZ131 orslomutant GAS strain as described previously. At the selected
time postuptake, cells werewashed and detachedwithAccutase for 15min
and centrifuged at 250 g for 5min. Cells were resuspended in 3%PFA in
PBS for 15 min and then centrifuged. The fixed cells were resuspended in
10% HS in PBS-saponin containing anti-GAS primary antibody for
30min, and then cells were washed twice by centrifugation and resuspen-
sion in PBS and incubated in the secondary antibody for 30 min. After
labeling, cells were resuspended in PBS for analysis by flow cytometry.
Analysis was carried out with a two-laser, four-color FACSCalibur flow
cytometer (BD Biosciences). Uninfected cells were used to calibrate the
instrument settings. Fluorescence-activated cell sorting data were ana-
lyzed with FlowJo software version 7.6.5 (TreeStar).
Live imaging.WTU937 cells orU937 cells stably expressingmCherry-
tagged galectin 3were differentiated on a 35-mmglass-bottomdish 3 days
prior to infection with GFP-M1T1 5448 GAS as described previously. At
1 h 30 min prior to imaging, the medium was replaced with Opti-MEM
(Gibco) imaging medium supplemented with 5% FCS, 10 mM HEPES,
and 25 g/ml gentamicin. The dish was transferred to the confocal mi-
croscope and mounted onto an automated stage fully enclosed within a
37°C live-cell chamber. The dish was left undisturbed for 20min tomain-
tain temperature stability within the chamber. Live imaging with a 63
objective was initiated at 2 hpu and continued until 10 hpu. Multiposi-
tional acquisition was used to select and record approximately 20 to 30
different fields of view that contained infected cells with at least one bac-
terium or one galectin-positive GCV. Images were acquired every 20 min
for each selected position by means of the automated motorized stage.
Imaging movies were processed with ImageJ and Fiji software.
Digitonin permeabilization. To label and quantify intracellular cyto-
solic bacteria, differentiated U937 macrophages were infected with the
isogenic M49 NZ131 or slo mutant GAS strain as described previously.
At the selected time postuptake, cells were washed twice in PBS and incu-
bated on ice for 2 to 3 min. Cells were gently washed twice in ice-cold
sterile KHM buffer (110 mM potassium acetate, 20 mM HEPES, 2 mM
MgCl2 in PBS) and incubated in 500 l of ice-cold digitonin in KHM
buffer at concentrations of 20, 40, and 50 g/ml for approximately 5 min
on ice. Cells were gently washed once with ice-cold KHMbuffer and once
more with ice-cold PBS. To label the cytosolic bacteria, the primary anti-
GAS antibody was prepared in 10%HS in PBS and 200l was transferred
onto the cells for 30 min at room temperature. Cells were gently washed
twice in PBS and fixedwith 3%PFA for 10min. Cells werewashed twice in
PBS and incubated in secondary antibody in 10% HS--PBS for 1 h. To
label the total bacteria (vacuolated and cytosolic), the cells were washed
and incubated first with an anti-GAS primary antibody and then with a
different Alexa Fluor-conjugated secondary antibody in 10% HS--PBS
with 0.1% saponin. Each experiment was carried out with three different
concentrations to assess the efficacy of selective permeabilization, andHK
bacteria were used as the internal negative control. Each experiment was
carried out in duplicate with three independent repeats.
Statistical analysis. Data are expressed as mean  SEM. Statistical
testing was carried out with two-tailed Student t tests of data from exper-
imental assays repeated at least three times. P values of 0.05 were con-
sidered statistically significant.
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